Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering
Attovia Therapeutics priced an upsized initial public offering of 17 million shares at $17.00 per share, generating expected gross proceeds of approximately $289 million. The company's common stock is set to begin trading on the Nasdaq Global Market on August 5, 2026, under the symbol 'ATTO', with underwriters granted a 30-day option to purchase an additional 2.55 million shares.
Key figures
- Deal Value Usd
- 289000000
- Offering Price
- 17
- Shares Offered
- 17000000
- Exchange
- Nasdaq Global Market
- Ticker symbol
- ATTO
- Greenshoe shares
- 2550000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.